ArticleJournal of imaging2025
Multi-Channel Spectro-Temporal Representations for Speech-Based Parkinson's Disease Detection.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Machine Learning Approach to Voice-Based Parkinson Disease Screening Using Multiview Spectrogram and Speech Recognition Features: Diagnostic Study.JMIR medical informatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Early, non-invasive detection of Parkinson's Disease (PD) using speech analysis offers promise for scalable screening. In this work, we propose a multi-channel spectro-temporal deep-learning approach for PD detection from sentence-level speech, a clinically relevant yet underexplored modality. We extract and fuse three complementary time-frequency representations-mel spectrogram, constant-Q transform (CQT), and gammatone spectrogram-into a three-channel input analogous to an RGB image. This fused representation is evaluated across CNNs (ResNet, DenseNet, and EfficientNet) and Vision Transformer using the PC-GITA dataset, under 10-fold subject-independent cross-validation for robust assessment. Results showed that fusion consistently improves performance over single representations across architectures. EfficientNet-B2 achieves the highest accuracy (84.39% ± 5.19%) and F1-score (84.35% ± 5.52%), outperforming recent methods using handcrafted features or pretrained models (e.g., Wav2Vec2.0, HuBERT) on the same task and dataset. Performance varies with sentence type, with emotionally salient and prosodically emphasized utterances yielding higher AUC, suggesting that richer prosody enhances discriminability. Our findings indicate that multi-channel fusion enhances sensitivity to subtle speech impairments in PD by integrating complementary spectral information. Our approach implies that multi-channel fusion could enhance the detection of discriminative acoustic biomarkers, potentially offering a more robust and effective framework for speech-based PD screening, though further validation is needed before clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.